US IVD Market Future Discussed in New Report Recently Published at Marketpublishers.Com
13 Jan 2012 • by Natalie Aster
LONDON – How will the future reimbursement changes affect individual market segments? Will the industry consolidate, decentralize, or undergo a bimodal transformation? What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers, licensing, import and export? How will the future technological advances affect the major market segments? Which companies will enter the market and which will not survive? The answers to all these and other key strategic questions can be found in the research report.
New research report “The US In Vitro Diagnostics Market Outlook: Strategic Implications of Emerging Reimbursement, Technological and Market Trends through 2018” prepared by Venture Planning Group has been recently published by Market Publishers Ltd.
Title: The US In Vitro Diagnostics Market Outlook: Strategic Implications of Emerging Reimbursement, Technological and Market Trends through 2018
Published: January, 2012
Price: US$ 4,850
The report delves into in-depth analysis of the U.S. in vitro diagnostics market’s future. It evaluates emerging markets and technologies presenting unexpected threats or offering opportunities; features major regulatory, economic, demographic and social trends; as well as offers five- and ten-year test volume and sales forecasts for key testing locations and laboratory disciplines.
Market segments covered in the report include: clinical chemistry and immunodiagnostics, microbiology and serology, hematology and flow cytometry, blood banking, histology and cytology, coagulation, urinalysis.
Technologies covered include: molecular diagnostics, monoclonal antibodies, solid phase chemistry, biosensors and biochips, automation and robotics, IT.
More new market research reports by the publisher can be found at Venture Planning Group page.
The Market Publishers, Ltd.
Tel: +44 208 144 6009
Fax: +44 207 900 3970